What is the assessment and treatment plan for a patient with atopic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessment and Management of Atopic Dermatitis

The cornerstone of atopic dermatitis management is a combination of daily emollient use, topical anti-inflammatory therapy, trigger avoidance, and educational interventions, with systemic therapy reserved for severe or refractory cases. 1

Assessment

Disease Severity Evaluation

  • Assess extent and intensity of skin lesions (erythema, edema/papulation, excoriations, lichenification)
  • Evaluate distribution pattern (flexural surfaces in children, extensor surfaces in infants, hands/face in adults)
  • Document pruritus severity and sleep disturbance
  • Consider impact on quality of life and daily functioning

Trigger Identification

  • Environmental irritants (acids, bleaches, fragrances, solvents, wool)
  • Temperature and humidity extremes
  • Emotional stress
  • Potential allergens (only test if clinically indicated)

Treatment Algorithm

First-Line Therapy

  1. Skin Care and Barrier Repair

    • Apply fragrance-free emollients immediately after bathing and 2-4 times daily 1, 2
    • Continue emollient use even when skin appears normal to prevent relapse 2
    • Use gentle, soap-free cleansers 2
  2. Topical Anti-inflammatory Therapy

    • Topical Corticosteroids (TCS)

      • First-line treatment for flares 1
      • Match potency to severity and location:
        • Low potency (1% hydrocortisone): Face, intertriginous areas
        • Medium potency: Trunk, extremities
        • High potency: Lichenified areas, palms/soles
      • Apply twice daily during flares
      • Limit high-potency TCS to 2 consecutive weeks; amounts >50g/week should be avoided 3
    • Topical Calcineurin Inhibitors (TCI)

      • Tacrolimus 0.03% (children), 0.1% (adults)
      • Pimecrolimus 1%
      • Particularly useful for face, neck, intertriginous areas
      • May cause initial burning/stinging sensation 1
  3. Flare Prevention (Proactive Therapy)

    • After disease stabilization, continue TCS 1-2× weekly or TCI 2-3× weekly to previously affected areas 1
    • This approach significantly reduces risk of flares and extends time to relapse 1
  4. Educational Interventions

    • Educational programs and "eczema schools" improve outcomes 1
    • Video interventions and nurse-led programs are beneficial 1

Second-Line Therapy

  1. Phototherapy

    • Consider when first-line treatments fail 1
    • Narrowband UVB is preferred modality 1
    • Typical regimen: 2-3 sessions/week initially 2
    • Can be used as maintenance therapy for chronic disease 1
  2. Wet Wrap Therapy

    • For severe flares unresponsive to standard therapy
    • Maximum duration of 14 days 2
    • Apply TCS, then cover with wet bandages followed by dry layer

Third-Line Therapy (Severe/Refractory Cases)

  1. Systemic Immunomodulators

    • Consider when disease is severe and refractory to topical therapy and phototherapy 1
    • Options include:
      • Dupilumab (FDA approved for patients ≥6 months) 2
      • Cyclosporine (3-6 mg/kg/day divided in two doses) 2
      • Methotrexate
      • Azathioprine
      • Mycophenolate mofetil
  2. Systemic Corticosteroids

    • Generally not recommended due to risk of rebound flares upon discontinuation 2
    • Reserve only for most severe acute exacerbations as bridge therapy 2

Adjunctive Measures

Antihistamines

  • Limited evidence for efficacy in reducing pruritus 1
  • May be helpful for sleep disturbance due to sedating effects
  • Not recommended as routine treatment 4

Antimicrobials

  • Only use for clinically infected skin
  • Consider bleach baths for recurrent infections 4

Environmental Modifications

  • Temperature and humidity control
  • Cotton clothing preferred over wool or synthetic fabrics 1
  • Avoid activities causing excessive sweating 1

Special Considerations

Food Allergies

  • Do not recommend food elimination diets based solely on allergy test results 1
  • Consider food allergy evaluation in children <5 years with moderate-to-severe AD if:
    • Persistent AD despite optimal treatment, OR
    • History of immediate reaction after food ingestion 1, 5

Allergen Testing

  • Only test for allergies when clinically indicated by history 1
  • Patch testing should be considered for persistent/recalcitrant disease 1

Complementary Therapies

  • Insufficient evidence to recommend Chinese herbal therapy, massage therapy, aromatherapy, or naturopathy 1
  • No consistent evidence to support use of probiotics, prebiotics, fish oils, evening primrose oil, or vitamin supplements 1

When to Refer to a Specialist

  • Diagnostic uncertainty
  • Failure to respond to appropriate therapy
  • Consideration of systemic therapy
  • Significant impact on quality of life despite treatment
  • Need for allergen testing or dietary manipulation

Common Pitfalls to Avoid

  • Overuse of high-potency topical corticosteroids on sensitive areas
  • Discontinuing treatment too early after improvement
  • Indiscriminate allergy testing without clinical correlation
  • Unnecessary dietary restrictions
  • Inadequate patient education about chronic nature of disease
  • Failure to implement proactive maintenance therapy

By following this structured approach to assessment and management, most patients with atopic dermatitis can achieve good disease control and improved quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Skin Conditions Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atopic Dermatitis Part 2: Management.

Pediatrics in review, 2025

Research

Atopic dermatitis and its relation to food allergy.

Current opinion in allergy and clinical immunology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.